Correlation Between Molecular Partners and MoonLake Immunotherapeuti

Can any of the company-specific risk be diversified away by investing in both Molecular Partners and MoonLake Immunotherapeuti at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and MoonLake Immunotherapeuti into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Molecular Partners AG and MoonLake Immunotherapeutics, you can compare the effects of market volatilities on Molecular Partners and MoonLake Immunotherapeuti and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of MoonLake Immunotherapeuti. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and MoonLake Immunotherapeuti.

Diversification Opportunities for Molecular Partners and MoonLake Immunotherapeuti

0.54

Correlation Coefficient

Molecular Partners  MoonLake Immunotherapeuti

Very weak diversification

The 3 months correlation between Molecular and MoonLake is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and MoonLake Immunotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MoonLake Immunotherapeuti and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with MoonLake Immunotherapeuti. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MoonLake Immunotherapeuti has no effect on the direction of Molecular Partners i.e., Molecular Partners and MoonLake Immunotherapeuti go up and down completely randomly.

Pair Corralation between Molecular Partners and MoonLake Immunotherapeuti

Given the investment horizon of 90 days Molecular Partners AG is expected to generate 1.52 times more return on investment than MoonLake Immunotherapeuti. However, Molecular Partners is 1.52 times more volatile than MoonLake Immunotherapeutics. It trades about -0.01 of its potential returns per unit of risk. MoonLake Immunotherapeutics is currently generating about -0.15 per unit of risk. If you would invest  499.00  in Molecular Partners AG on December 30, 2024 and sell it today you would lose (43.00) from holding Molecular Partners AG or give up 8.62% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Molecular Partners AG  vs.  MoonLake Immunotherapeutics

Molecular Partners

Risk-Adjusted Performance

Very Weak

Over the last 90 days Molecular Partners AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Molecular Partners is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

MoonLake Immunotherapeuti

Risk-Adjusted Performance

Very Weak

Over the last 90 days MoonLake Immunotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Molecular Partners and MoonLake Immunotherapeuti

The main advantage of trading using opposite Molecular Partners and MoonLake Immunotherapeuti positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, MoonLake Immunotherapeuti can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MoonLake Immunotherapeuti will offset losses from the drop in MoonLake Immunotherapeuti's long position.

The idea behind Molecular Partners AG and MoonLake Immunotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.